Subject
General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference24 articles.
1. Remogliflozin etabonate: first global approval;Markham;Drugs,2019
2. Remogliflozin etabonate in the treatment of type 2 diabetes: design, development, and place in therapy;Mohan;Drug Des Dev Ther,2020
3. Glenmark launches novel, globally researched anti-diabetes drug remogliflozin in India;Glenmark Pharmaceuticals,2019
4. Minutes of IND committee meeting held on 15.03.2019 at ICMR (HQ). Agenda no. 3: application for marketing authorization of remogliflozin of M/s Glenmark Pharmaceuticals;Ind Committee,2019
5. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials;Higgins;BMJ,2011
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献